2. Company Profile* About the Company Today’s Abdi Ibrahim
Shareholders: Barut and Esirtgen Families
Abdi Ibrahim Tower: Istanbul, Turkey
Production and R&D: Esenyurt, Istanbul
Turnover: $853 million
Export: $27 million
Production Capacity: 350 million boxes
Product Range: 53% original pharmaceuticals
47% generic pharmaceuticals
Licensors: ~ 30 international companies
Employees: ~ 3,300
Today’s Abdi Ibrahim
* As of December 2011

3. Vision Mission About the Company
To be a well-respected, widely preferred global player that strives to grow more rapidly than the respective pharmaceutical market
Mission
To produce and supply healthcare products through a pioneering and innovative approach, for the benefit of medicine and humanity

4. A Journey of 100 Years to the Summit
About the Company
A Journey of 100 Years to the Summit
Istanbul
Istanbul
Algeria
The business started in 1912 with a small pharmacy in Istanbul
In 1940, the number of drugs produced at the Abdi Ibrahim Laboratory reached 80
The foundations of the production facilities were laid in 1994
In 1999, international expansion started with the first venture into Algeria
Portfolio: 150 brands, more than 250 products, close to 30 licensors, exports to more than 20 countries
EU GMP approved manufacturing facility and first accredited R&D

5. Industry Leader for 9 Years
Turnover — Consolidated Turnover (Millon $)
Turnover — Consolidated Turnover (TL)
* As of December 2011

6. Domestic Sales Development
Industry Leader
Domestic Sales Development
Turnover Development (TL)
Turnover Development ($ mio)
Manufacturing (2)
Domestic sales (contract man. included)
Domestic sales turnover (contract man. included)
* As of December 2011

7. Market Share — $ Turnover (2011)
Industry Leader
Market Share Leader in Turkey
Market Share — Units (2011)
Market Share — $ Turnover (2011)
Ref. IMS

8. Industry Leader
Export Development

9. $274 Million Investment (1990-2011)
Industry Leader
$274 Million Investment ( )
Fixed Assets
$ million

10. The Largest Sales and Marketing Team in Turkey (2010 - 2011)
Industry Leader
Success is a Team Game
The Largest Sales and Marketing Team in Turkey ( )
Number of employees ~ 3300*
* Includes Abdica, Reformed and International Markets

11. First Accredited R&D Center in Turkey
Manufacturing Plant
Production Capacity: 350 million boxes
Production Area: 25,000 sqm
Employees: > 500
Adhering to global standards
cGMP and cGLP certifications
ISO Environmental Management System Certification
OHSAS Work Safety Certification
EU GMP approved facility
“Energy-Efficient Industrial Facility” Award in 2007
Modern, efficient and environment-friendly technology
2D Matrix Codes technology in the production line automation system
Logistic Center
Closed Area: 22,000 sq m
Total Palette Capacity: 14,500
With an investment of $35 million, Abdi Ibrahim Logistic Center is equipped with the latest state-of-the-art equipment allowing for faster transport and greater performance with fully automation system
First Accredited R&D Center in Turkey
Total Closed Area: 13,600 sq m
Laboratory: 2,000 sq m
Pilot Production Area: sq m
Offices: sq m
Storage Area: sq m
Employees: > 150
High level of success in bioequivalence studies
CTD files for Turkey and Europe
Accelerated development process for equivalent products
Development of value-added products

12. Abdi Ibrahim Global Global Reach Export to more than 20 Countries
Production of Original and Generic Pharmaceuticals
Licensing
Marketing and Registration

13. Global
Licencors

14. List of Countries Aİ Operates Own Markets Third Party Countries
(Operation through own organization/reps)
Third Party Countries
(Operation through distributor)
Afghanistan
Vietnam
Yemen
Albania
Libya
Hong Kong
Jordan
Russia
Turkmenistan
Algeria
Kazakhstan
Azerbaijan
Georgia
Ukraine
Iraq
Moldova
Kosovo
Lebanon
Germany
France UK
Belgium
Netherlands
Canada
Uganda, Sudan, Mauritius

15. Outlicensing Countries ( As of 2012)
List of Countries Aİ
Operates
Outlicensing Countries ( As of 2012)
Brazil
Venezuella
South Africa
Tunusia
Morocco
Austria
Spain
Switzerland
Hungary
Bulgaria
Croatia
GCC

16. 100th Year Rational Medicine Usage Campaign
Undertaking responsibility on the “Rational Medicine Use” campaign initiated by the World Health Organization for the first time in 1985 and applied by the T.R. Ministry of Health since 1992, Abdi İbrahim aims to contribute to preventing the effects of irrational medicine use on the public health and economy.
Transmitting its messages to the public with the collaboration of doctors and pharmacists via visual and printed materials in health institutions within the context of the Rational Medicine Use Campaign, Abdi İbrahim also aims to contribute to preventing the waste of resources and establishment of a healthier society by reaching a broader audience via TV ads, radio spots and magazine advertisements.
Van Gogh Alive
The Turkish pharmaceutical industry leader, Abdi İbrahim, will be celebrating its 100th anniversary with an impressive exhibit never before experienced, in which the works of one of the most famous artists in the world, Vincent Van Gogh, will be presented in a whole new format.
This exhibit, where the famous works of Vincent Van Gogh come to life at enormous scale, immersing the audience in a vibrant symphony of light, color & sound reflects Abdi İbrahim’s 100 year vision, by blending art, science and technology with an innovative approach.